2012-10-15 14:39:22 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Mahachai Hospital Public Company Limited and produced a Rating Update Report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering Mahachai Hospital Public Company Limited (M-CHAI). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Mahachai Hospital Public Company Limited investor.
Report Summary: Mahachai Hospital Public Company Limited is a below average quality company with a negative outlook. Mahachai Hospital Public Company Limited has medium business growth and is run by efficient management. The trend in Mahachai Hospital Public Company Limited fair value exchange rate against its closest rated-competitor, Sikarin PCL, has been stable over the past 2 weeks. When compared to its closest competitor, Mahachai Hospital Public Company Limited shows less overvaluation and is equally likely to underperform
The 3-page report breaks down the Total StockMark into its three components – business, management and price, performing an in-depth analysis of Mahachai Hospital Public Company Limited for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.